GTBP - GT Biopharma Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.7 0.02 (2.51%)	---	0.0 (0.0%)	0.0 (0.0%)	0.02 (2.51%)	---	0.0 (-0.15%)	0.01 (1.12%)

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.55
Diluted EPS:: -0.55
Basic P/E:: -1.3091
Diluted P/E:: -1.3091
RSI(14) 1m:: 100.0
VWAP:: 0.72
RVol:: 0.0055

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.72 +0.02 (+3.39%)	Oct 15 07:49
1m	Price decrease 1m	0.69 -0.02 (-2.65%)	Oct 15 06:02
10m	Price decrease 10m	0.71 -0.03 (-4.56%)	Oct 14 19:58
1m	Price increase 1m	0.74 +0.01 (+1.37%)	Oct 14 19:25